From: PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
True toxicity probability
Early stopping probability
Average sample size
0.2
0.052
29.2
0.3
0.273
25.8
0.4
0.623
20.1
0.5
0.884
14.9
0.6
0.982
11.8